Oramed Pharmaceuticals
ORMP
ORMP
50 hedge funds and large institutions have $8.15M invested in Oramed Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 23 closing their positions.
Holders
50
Holders Change
-11
Holders Change %
-18.03%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
10
Reduced
14
Closed
23
Calls
$499K
Puts
$49K
Net Calls
+$450K
Net Calls Change
+$217K
Top Buyers
Top Sellers
| 1 |
BCM
1
BML Capital Management
Zionsville,
Indiana
|
$3.04M |
| 2 |
2
Two Sigma Investments
New York
|
$213K |
| 3 |
3
Two Sigma Advisers
New York
|
$682K |
| 4 |
4
Morgan Stanley
New York
|
$157K |
| 5 |
5
JPMorgan Chase & Co
New York
|
$193K |
